Journal
ONCOTARGET
Volume 6, Issue 28, Pages 26002-26017Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4692
Keywords
ovarian clear cell carcinoma; HNF1 beta; metabolome analysis; aerobic glycolysis; ROS
Categories
Ask authors/readers for more resources
HNF1 beta is expressed exclusively in ovarian clear cell carcinoma (OCCC) and not in other ovarian cancers, regarded as a hallmark of this tumor. This implies its central role in the unique character of OCCC, including resistance to chemotherapy, but its exact role and influence in cancer biology or the molecular bases of its function are largely unknown. Using comprehensive metabolome analysis of HNF1 beta_shRNA-stable cell lines, we show here that HNF1 beta drastically alters intracellular metabolism, especially in direction to enhance aerobic glycolysis, so called the Warburg effect. The consequence of the metabolic change contributed cell survival under stresses such as hypoxia and chemo-reagent, only when sufficient glucose supply was available. Augmented cell survival was based on the reduced ROS activity derived from metabolic alteration such as shift from oxidative phosphorylation to glycolysis and increased intracellular anti-oxidant, glutathione (GSH). One of the cystine transporters, rBAT is likely to play a major role in this GSH increase. These data suggest that HNF1 beta, possibly induced by stressful microenvironment in the endometriotic cyst, confers survival advantage to the epithelial cells, which leads to the occurrence of OCCC, a chemo-resistant phenotype of ovarian cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available